Download Files:
Products Details
Product Description
– ERK1/2 inhibitor 6 is a potent inhibitor of ERK1/2. Mitogen-activated protein kinase (MAPK) plays an extremely important role in the signal transduction pathway, and extracellular signal regulated kinase (ERK) is a member of the MAPK family. ERK1/2 inhibitor 6 has the potential for the research or prevention of cancer, inflammation or other proliferative diseases (extracted from patent WO2021063335A1, compound 1)[1].
Web ID
– HY-145028
Shipping
– Room temperature
Applications
– COVID-19-immunoregulation
Molecular Formula
– C27H29ClFN7O5
References
– [1]Jin Li, et al. Erk1/2 protein kinase inhibitors and their uses. Patent WO2021063335A1.
CAS Number
– 2634816-13-8
Molecular Weight
– 586.01
SMILES
– O=C1C2=CC(C3=NC(NC4CCOCC4)=NC=C3Cl)=CN2N=CN1[C@H](C)C(N[C@@H](C5=CC(OC)=CC(F)=C5)CO)=O
Clinical Information
– No Development Reported
Research Area
– Cancer; Inflammation/Immunology
Solubility
– 10 mM in DMSO
Target
– ERK
Pathway
– MAPK/ERK Pathway;Stem Cell/Wnt
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
